Zimmer Biomet/ZBH

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Zimmer Biomet

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Ticker

ZBH

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

Warsaw, United States

Employees

18,000

Zimmer Biomet Metrics

BasicAdvanced
$22B
Market cap
23.03
P/E ratio
$4.62
EPS
1.02
Beta
$0.96
Dividend rate
0.90%
Dividend yield
$22B
1.02
$0.96
1.656
0.658
39.654
47.626
20.75%
7.44%
4.44%
7.80%
23.03
2.96
1.73
-23.74
27.36
0.90%
4.85%
115.66%
2.89%
19.15%

What the Analysts think about Zimmer Biomet

Analyst Ratings

Majority rating from 29 analysts.
Hold

Zimmer Biomet Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
9.12% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.9B
-2.62%
Net income
$172M
-58.87%
Profit margin
9.12%
-57.78%

Zimmer Biomet Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.78%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.82
$1.65
$2.20
$1.94
-
Expected
$1.81
$1.60
$2.15
$1.87
$1.99
Surprise
0.57%
3.28%
2.11%
3.78%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

Jul
31
Zimmer Biomet
Dividend·Payment
$0.24
Per share

FAQs

What’s the current market cap for Zimmer Biomet stock?

Zimmer Biomet (ZBH) has a market cap of $22B as of July 03, 2024.

What is the P/E ratio for Zimmer Biomet stock?

The price to earnings (P/E) ratio for Zimmer Biomet (ZBH) stock is 23.03 as of July 03, 2024.

Does Zimmer Biomet stock pay dividends?

Yes, the Zimmer Biomet (ZBH) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $0.96 and the yield is 0.9%. Zimmer Biomet has a payout ratio of 20.75% on a trailing twelve-month basis.

When is the next Zimmer Biomet dividend payment date?

The next Zimmer Biomet (ZBH) dividend payment is scheduled for July 31, 2024.

What is the beta indicator for Zimmer Biomet?

Zimmer Biomet (ZBH) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Zimmer Biomet stock

Buy or sell Zimmer Biomet stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing